Healthcare Room I
The Problem Room
The evidence. Reports, studies, lawsuits, and government investigations detailing the systemic machinery of denial — documented, cited, and sourced.
Table of Contents
- Systemic Denial Practices
- 🔍 Why Claims Are Really Denied — Myth vs. Reality
- Legal Challenges & Lawsuits
- Government Investigations & Scrutiny
- Market Power & Hospital Conflicts
- 🚨 The Displacement — Healthcare Refugees & Governor Shapiro's Emergency Exit
- Drug Pricing & PBM Issues
- Whistleblower Accounts & Patient Stories
- 🤖 AI as Weapon vs. Tool — Same Technology, Provably Different Intent
- External Health Insurance Watchlists & Resources
Systemic Denial Practices
Medicare Advantage Insurers Made Nearly 50 Million Prior Authorization Determinations in 2023
A KFF analysis found that Medicare Advantage insurers processed a staggering 49.8 million prior authorization requests in 2023 — up from 37 million in 2021 — averaging more than 4 requests for every single MA enrollee.
- Insurers denied 3.7 million requests. Only 11.7% of those denials were appealed — yet 81.7% of appealed denials were overturned in the patient's favor, suggesting millions of initial denials were improper.
- Total prior authorization requests: 49.8 million. Total denied: 3.7 million (7% of all requests).
- If 81.7% of all 3.7 million denials are as wrongful as those that were appealed, that is 3 million victims of the Denial Echo Chamber per year.
- Services with high denial rates included home health (15%) and skilled nursing facility stays (12%).
IRE Overturn Rates — The Insurers Above the Industry Average
Industry average: 81.7% of denied claims overturned at Independent Review. The following insurers exceed even that. These are not outliers — they are the top of a chart where the bottom is already indefensible.
93.6%
Centene
6.4% of denials upheld
89.7%
CVS / Aetna
10.3% of denials upheld
86.0%
Cigna
14% of denials upheld
85.2%
UnitedHealthcare
14.8% of denials upheld
These numbers have a specific meaning that gets lost in the abstraction of percentages. Centene issues a denial. An independent physician — with no financial stake in the outcome — reviews it. 93.6% of the time, that physician says Centene was wrong.
Centene knows this. Every insurer on this list knows their own overturn rate. They issue the denial anyway — because only 0.2% of patients ever appeal. For every 1,000 denials Centene issues, approximately 2 patients appeal, roughly 1.87 win, and 998 patients accept a denial that an independent physician would have overturned 936 times.
That is not a medical disagreement rate. That is a business model built on the near-certainty that patients will not fight back.
Read the KFF Article →
Claims Denials and Appeals in ACA Marketplace Plans in 2023
Insurers on the ACA Marketplace denied 19% of all in-network claims in 2023 — nearly 1 in 5 medical services that were already performed by an in-network doctor were retroactively denied. UnitedHealthcare was above average at 33%.
- Consumers almost never appeal. Of the 73 million denied in-network claims, patients filed formal appeals for less than 1%. When they did appeal, insurers upheld their own denial 56% of the time.
- Insurers processed 425 million claims in 2023, denying 73 million in-network claims.
- The most common reason given for denial: "Other" (34%), followed by "Administrative reason" (18%). Only 6% of denials cited lack of medical necessity.
- Blue Cross Blue Shield of Alabama denied 35% of in-network claims; UnitedHealth Group denied 33%.
Why Claims Are Really Being Denied — Myth vs. Reality
The public narrative focuses on "Not Medically Necessary" as the leading cause of denials. The data tells a different story. Here is what 2024 HealthCare.gov plan denials actually look like — every figure represents 5% of all denied claims.
The Common Assumption
other reasons...
Assumed #1 Cause
"Not Medically Necessary"
The public assumes this is the primary reason for denials.
Consumer Survey Highlights Problems with Denied Health Insurance Claims
A KFF survey of insured adults found that nearly 1 in 5 (18%) reported having a claim denied in the past year. For those who experienced a denial, only 29% reported their "biggest problem" was ultimately resolved to their satisfaction.
- Among patients with a denied claim, 24% said their health declined as a result, and 24% said they were unable to receive care recommended by their doctor.
- 58% of all insured adults reported experiencing at least one problem with their insurance in the past year.
- Denials were most common for employer-sponsored plans (21%) and marketplace plans (20%).
- 69% of those with a denied claim didn't know they could appeal. 86% didn't know what government agency to contact for help.
⚠️ What These Statistics Look Like in Practice
The data above describes the systemic pattern. Here is what that pattern looks like when it lands on one person — and why the numbers above are not just statistics but a documented causal chain.
Apligraf® (PMA P950032) is a living, bi-layered skin substitute that received FDA expedited review authorization in 1995 and full federal approval in 1998 and 2000. It is not experimental. It is not unproven. The FDA's own pivotal clinical trial established the following, subsequently confirmed and strengthened by 25 years of real-world evidence:
60%
Reduction in amputation risk
(6.3% vs 15.6%, p=0.028)
75%
Reduction in osteomyelitis risk
(bone infection: 2.7% vs 10.4%, p=0.04)
2 weeks
Time to wound closure once
finally approved after 17-month denial
UnitedHealthcare denied Apligraf for 17 months — citing it as "not medically necessary" — while non-healing wounds progressed. The patient subsequently developed osteomyelitis. Pathology from the eventual amputation described bone demineralized to a consistency "cuttable with a scalpel." The bone infection that caused the amputation is precisely the outcome the FDA trial proved Apligraf reduces by 75%.
When Apligraf was finally approved, it closed the wounds in two weeks. This vindicates the standard UHC suppressed for 17 months and establishes the 17-month delay as the proximate cause of the harm — not the underlying condition.
The thread lawyers struggle to follow — stated plainly:
This is not a medical disagreement about whether a treatment works. The federal government resolved that question in 1995–2000. This is a documented, foreseeable causal chain:
- FDA proves Apligraf reduces bone infection risk by 75% and amputation risk by 60%.
- UHC denies Apligraf for 17 months, citing "not medically necessary."
- Patient develops bone infection severe enough to require amputation.
- UHC's own IRE overturn rate of 85.2% means the denial was almost certainly wrongful by the insurer's own statistical pattern.
- When Apligraf is finally approved, wounds close in two weeks — proving the standard was never in dispute, only the insurer's willingness to honor it.
The denial didn't just delay treatment. It denied a treatment the federal record proves prevents the exact harm that followed. That foreseeability is what distinguishes this from a coverage dispute.
The full legislative response — including the Clinical Integrity Amendment, S.3829, and H.R. 6852 — is documented in The Remedy Room →
Legal Challenges & Lawsuits
Ballad Health Sues UnitedHealth Group, Alleging Medicare Advantage Manipulation and Harm to Patients
Ballad Health filed a federal lawsuit against UnitedHealth Group, alleging the insurer systematically denies, delays, or underpays for medically necessary care for Medicare Advantage patients. The first time Ballad Health has taken legal action against an insurer — called a "last resort" after years of failed resolution attempts.
- The lawsuit alleges UnitedHealth improperly uses a "blatantly flawed" AI model to override physicians and prematurely deny post-acute care coverage, leaving patients hospitalized longer than necessary and increasing their risk of hospital-acquired conditions.
- The suit claims UnitedHealth withheld "millions of dollars" it had previously agreed to pay for patient care, and alleges a pattern of overstating how sick patients are to collect higher government payments while simultaneously denying claims.
Estate of Gene B. Lokken et al. v. UnitedHealth Group, Inc. et al.
A federal class-action lawsuit filed by estates of deceased Medicare Advantage patients alleges UnitedHealth Group illegally used an AI model to deny post-acute care to elderly patients. A federal judge allowed the case to proceed on breach of contract and breach of implied covenant of good faith and fair dealing.
- The AI model, "nH Predict," is alleged to be "notoriously inaccurate" with an error rate over 90%. The suit claims UHG knew of these flaws but used the algorithm to override physicians' recommendations, leading to "worsening injury, illness, or death."
- UHG knew only about 0.2% of policyholders would appeal the AI-powered denials. When denials were appealed, over 90% were reversed — demonstrating the model's blatant inaccuracy.
- The suit claims UHG employees were disciplined or terminated if they deviated from the AI's "rigid and unrealistic" predictions, regardless of the patient's actual medical needs.
Judge Rips Insurance Company for 'Immoral, Barbaric' Cancer Denials
A federal judge recused himself from a case where UnitedHealthcare denied coverage for proton beam therapy to a child with cancer — revealing he himself had been diagnosed with cancer and was initially denied the same treatment by his own insurer.
- Judge Robert W. Schroeder III was diagnosed with base-of-tongue cancer in 2018. His insurer denied proton beam therapy initially; it was later approved after appeal.
- The case he recused himself from involved A.F., a child with Ewing sarcoma, whose UnitedHealthcare plan denied the same therapy. The judge found the parallel too close to remain impartial.
Read the CNN Article → Read the National Library of Medicine Article →
Senate Democrats Release Scathing Report on Medicare Advantage Denials
A Senate investigation into the three largest Medicare Advantage insurers (UnitedHealthcare, Humana, and CVS/Aetna) found the companies deny prior authorization requests for post-acute care at far higher rates than other care categories.
- In 2022, Humana denied post-acute care prior authorization requests at a rate more than 16 times higher than its overall denial rate for all PA types.
- UnitedHealthcare's post-acute care PA denial rate more than doubled — from 10.9% in 2020 to 22.7% in 2022.
- CVS and UnitedHealthcare both denied post-acute care requests at rates roughly three times higher than their overall denial rates.
- The number of CVS post-acute care requests requiring prior authorization increased 57.5% from 2019 to 2022.
Government Investigations & Scrutiny
FTC Accuses CVS, Cigna, UnitedHealth of Abusing Middleman Role
Following a nearly two-year investigation, the FTC formally accused the PBM units of CVS Health (Aetna), Cigna Group (Express Scripts), and UnitedHealth Group (Optum Rx) of anticompetitive practices that inflate drug costs and restrict patient access to medicines.
- The three companies control approximately 80% of the PBM market. The FTC's vote to pursue action was 3-0.
- Allegations include using complex contracts, rebates, and fees to steer patients to their own affiliated pharmacies and disadvantage competitors — increasing PBM profits at the expense of patients and payers.
DOJ Interviewing Former Employees About Medicare Billing Practices at UnitedHealth
The DOJ is actively investigating UnitedHealth Group's Medicare Advantage billing practices, with investigators interviewing former employees involved in coding patient diagnoses — indicating a deepening phase of the probe into how the company inflates risk scores for payment.
- The investigation centers on "upcoding" — whether UnitedHealth used in-home health assessments to add diagnoses and improperly inflate risk adjustment payments from Medicare by potentially billions of dollars.
- Previous reporting suggested these practices could have led to $8.7 billion in extra Medicare payments in 2021 alone — taken from American taxpayers.
Read the Fierce Healthcare Article → Read the Wall Street Journal Article →
Too Big to Fail? Lawmakers Are Eyeing a Breakup of UnitedHealth Group
Driven by UnitedHealth Group's immense size and alleged anticompetitive vertical integration, U.S. lawmakers and regulators are seriously considering antitrust action — including the possibility of breaking up the healthcare giant.
- UHG's Optum employs or is affiliated with roughly 90,000 physicians — making it the largest employer of doctors in the U.S. Optum also controls ~15% of the outpatient surgery market.
- Concerns focus on UHG steering patients to its own providers and pharmacies, using patient data anti-competitively, and using acquisitions like Change Healthcare to further consolidate power.
UnitedHealth Medicare Advantage Fraud Investigation
The DOJ is conducting a civil fraud investigation into UHG's Medicare Advantage billing practices — specifically whether the company improperly inflated payments by diagnosing patients with conditions that were not medically relevant or accurate ("upcoding").
- An HHS OIG report found UHG received over $3.7 billion from Medicare in 2023 for diagnoses made during in-home assessments and chart reviews that lacked follow-up treatment.
- Senator Chuck Grassley cited reports that UHG's inappropriate diagnoses resulted in $8.7 billion in extra Medicare payments in 2021 alone.
Following Ryan's Call, DOJ Launches Investigation into UnitedHealth
The DOJ launched an investigation into UnitedHealth Group's Medicare billing practices following calls from lawmakers including Rep. Pat Ryan — coming shortly after UnitedHealth announced staff reductions despite allegations of defrauding taxpayers of billions.
- Rep. Ryan called the alleged upcoding behavior "deeply disturbing" and potentially harmful to both taxpayers and seniors needing care.
- The investigation targets in-home Health Risk Assessments (HRAs) as the primary vehicle for inflating Medicare risk adjustment payments.
Justice Department Sues to Block UnitedHealth Group's Acquisition of Amedisys
The DOJ and Attorneys General of Minnesota and New York filed a civil antitrust lawsuit to block UHG's proposed acquisition of Amedisys, alleging the merger would substantially lessen competition in the home health services market across numerous states.
- The DOJ argued that allowing UHG's Optum — which already owns LHC Group — to also acquire Amedisys would harm vulnerable patients, including seniors and individuals with disabilities who rely on home health care.
- Alleged harms: higher prices, lower quality of care, reduced access, less innovation, and depressed wages for home health workers.
Trump DOJ Gives Monopolist UnitedHealth a Green Light to Swallow Yet Another Competitor
The Trump administration's DOJ settled the Biden-era antitrust lawsuit that was originally filed to block UnitedHealth Group's $3.3 billion acquisition of Amedisys — drawing immediate criticism that the deal represents political favoritism over patient protection.
- Critics including Senator Elizabeth Warren called the settlement "half-baked," alleging it allows UnitedHealth to divest required locations to "similarly conflicted buyers," including a private equity firm.
- The Biden-era DOJ had warned the merger would let UnitedHealth "further extend its grip" on home health care, "threatening seniors, their families, and nurses."
- A recent analysis cited in the article states that UnitedHealth Group currently has approximately 2,700 subsidiaries.
Change Healthcare Settlement: Proposed Final Judgment and Competitive Impact Statement
This document outlines the DOJ's settlement with UHG regarding the acquisition of Change Healthcare. To resolve antitrust concerns, UHG agreed to divest Change Healthcare's claims editing business (ClaimsXten) to private equity firm TPG Capital — allowing the main acquisition to proceed.
- The original DOJ lawsuit aimed to block the acquisition entirely because it alleged UHG (a major insurer) acquiring Change Healthcare (a critical data source for rival insurers) would give UHG unfair access to competitors' sensitive information.
- Legal basis: alleged violation of Section 7 of the Clayton Act.
NY Attorney General Takes Action to Protect Access to Health Services in Western New York
New York Attorney General Letitia James filed a lawsuit seeking a court order to prevent UnitedHealthcare from terminating contracts with Catholic Health System in Western New York, arguing the move would significantly harm healthcare access for thousands of New Yorkers.
- The termination would disproportionately affect seniors on Medicare Advantage and low-income individuals, removing in-network access to Mercy Hospital of Buffalo, Kenmore Mercy Hospital, and Sisters of Charity Hospital.
- AG James alleged UHC's action violates its obligations to maintain adequate provider networks and constitutes "irresponsible corporate behavior that prioritizes profits over patient well-being."
🚨 The Displacement — Healthcare Refugees Fleeing the Wrongful Denial Echo Chamber
Pennsylvania's Governor Had to Open an Emergency Exit
A contract dispute is when two parties disagree on price. What happened in the Lehigh Valley — and simultaneously across the country — is something different. It is what happens when health systems reach a breaking point with an insurer whose practices have become incompatible with providing care. You don't have to take anyone's word for it. Read what the institutions themselves said on the way out the door.
Johns Hopkins Medicine — August 25, 2025
Baltimore, Maryland · 60,000 patients displaced · Maryland, Virginia, Washington D.C.
After eight months of negotiations and five contract extensions, Johns Hopkins Medicine went out of network for approximately 60,000 UnitedHealthcare patients. Johns Hopkins stated explicitly that the impasse was not about money — both parties had agreed on rate increases. It was about something else.
"UnitedHealthcare refused to agree to reasonable terms that would ensure you receive the care you need, when you need it, without excessive delays or denials. We could not sign a contract that allows an insurance company to prioritize their profits over our patients' health."
— Johns Hopkins Medicine, Official Statement to Patients, August 2025
The specific UHC practices Johns Hopkins cited as barriers to patient care:
- Excessive prior authorization requirements that delay treatment
- Frequent treatment denials that force patients and doctors to fight for care
- Administrative burdens that take physicians and nurses away from patient treatment
- Delayed payments forcing the system to chase compensation instead of caring for patients
"United's current practices create real barriers to your care... While our negotiations with United have ended, it is still possible that we could come to an agreement in the future. However, as of right now, United is unwilling to remove problematic language from their contract — language that allows them to continue to delay and deny care coverage."
— Johns Hopkins Medicine, hopkinsmedicine.org/united-coverage
Read Johns Hopkins' Official Patient Statement → Read Fierce Healthcare's Coverage →
Lehigh Valley Health Network — January 26, 2026
Allentown, Pennsylvania · 5,400 Medicare Advantage patients displaced · Up to 50,000 commercial patients by April 26, 2026
In your backyard. LVHN, part of Jefferson Health, announced in October 2025 it would terminate its UHC contract after years of failed negotiations. On January 26, 2026, 5,400 Medicare Advantage patients lost in-network access. The contract dispute is not about rate increases — it is about UHC's unilateral reduction of already-agreed payments by nearly 40% since 2021, totaling over $100 million.
"For more than two years, Lehigh Valley Health Network has been working to establish an equitable relationship with UnitedHealthcare. Sadly, our efforts have been met with delays and obstacles as United continues its unfair payment practices. United refuses to pay LVHN in accordance with the rates and expectations that were originally agreed upon. We have worked tirelessly to reach a resolution with United, but they're not interested in finding a fair solution for our patients."
— Jefferson Health, Official Statement, October 2025
"The only thing misleading here is UnitedHealthcare portraying this as a standard negotiation when, in fact, this is a direct result of United not abiding by the terms of the contract they agreed to."
— Mark Whalen, EVP Jefferson Health, October 2025
"We worked tirelessly for more than two years to reach a responsible agreement, but UnitedHealthcare simply refused to meet its commitments. They refuse to acknowledge the issue that has reduced payments to LVHN by nearly 40%, creating avoidable financial hardship. That is not how partners behave — and it is certainly not how patients should be treated."
— Jeffrey Price, SVP Jefferson Health, January 2026
According to LVHN: UHC canceled scheduled meetings, ignored LVHN's proposals, and only offered one-sided solutions during negotiations.
Read LVHN's Official Patient Update → Read The Morning Call's Coverage →
The Pattern Is Not Local — It Is National
Among the most commonly cited reasons health systems nationwide are dropping Medicare Advantage plans: excessive prior authorization denial rates and slow payments from insurers. This is not an LVHN problem. It is not a Johns Hopkins problem. The Wrongful Denial Echo Chamber documented in this site is the mechanism driving health systems out of UHC networks from Oregon to Alabama, from Minnesota to New Orleans.
Mayo Clinic
Minnesota, Wisconsin, Iowa — Jan 1, 2026
OHSU
Oregon — "Not Sustainable"
Duke Health
North Carolina — 170,000 at risk
Corewell Health
Michigan
LCMC Health
New Orleans — 30,000 affected
M Health Fairview
Minnesota — 125,000 at risk
🏛️ Pennsylvania State Government Response — March 16, 2026
Governor Shapiro Opens Emergency Exit: Special Enrollment Period Through April 30, 2026
On March 16, 2026, the Shapiro Administration announced a special enrollment period — secured by directly petitioning the federal government at CMS — for the 5,400 Pennsylvanians stranded by the LVHN-UHC contract expiration. The Governor's office worked with the Pennsylvania Insurance Department and the Department of Aging to force open an emergency door that would not otherwise exist.
"It's frustrating that insurers and provider groups can't agree on reimbursement levels and leave Pennsylvanians just trying to maintain medical services or provider relationships holding the bag. We want all impacted UHC policyholders to know that resources are available to help them in this time of confusion."
— Pennsylvania Insurance Commissioner Michael Humphreys, March 16, 2026
During this special enrollment period, affected Medicare Advantage patients may move to traditional Medicare with a Medigap policy — without medical underwriting, meaning they cannot be denied coverage for pre-existing conditions. The enrollment window closes April 30, 2026.
These patients did not choose to leave. They were made unsafe. Johns Hopkins said so. LVHN said so. The state government of Pennsylvania had to petition the federal government to open an emergency exit. This is what the Wrongful Denial Echo Chamber looks like at scale — and this is why it must end.
Market Power & Hospital Conflicts
Mayo Clinic to Leave Most UnitedHealthcare and Humana Medicare Advantage Networks
Effective January 1, 2026, Mayo Clinic will no longer be an in-network provider for most individual Medicare Advantage plans from UnitedHealthcare and Humana — affecting patients at Mayo facilities in Minnesota, Wisconsin, and Iowa.
- In Minnesota, the number of insurers offering Medicare Advantage with in-network Mayo access will drop from five in 2025 to just two in 2026 — part of a larger trend that has Minnesota experiencing the second-largest drop in available Medicare Advantage plans in the nation.
Johns Hopkins and UnitedHealthcare Officially End Negotiations, Leaving 60,000 Patients Out-of-Network
After eight months of negotiations and five extensions, Johns Hopkins Medicine and UnitedHealthcare ended contract talks without agreement. As of August 25, Johns Hopkins facilities are out-of-network for most UHC members.
- Approximately 60,000 people in Maryland, DC, and Virginia are impacted — patients with employer-sponsored, individual, Medicare Advantage, and Medicaid plans all face higher costs or forced provider changes.
- The stalemate was reportedly not over money — both sides had agreed on financial terms. The dispute centered on contract language about patient care and denials.
- Johns Hopkins stated it would not agree to terms allowing an insurer to "prioritize profits over patients" through "excessive delays or denials" of care.
LVHN to Drop UnitedHealthcare Insurance Plans
Lehigh Valley Health Network (LVHN), part of Jefferson Health, announced it will terminate contracts with UnitedHealthcare in 2026 if a new agreement is not reached — citing UHC's failure to pay negotiated rates since 2021, resulting in reimbursement 40% below expected levels.
- Medicare Advantage contract ends January 25, 2026. Commercial insurance contract ends April 25, 2026.
Read the DelcoTimes Article → Read the LVHN Official Update →
'Not Sustainable': OHSU and UnitedHealthcare Near Contract Expiration
Oregon Health & Science University, a premier medical institution, warned patients it may be forced out of network with UnitedHealthcare, citing "administrative burdens" and denial rates that make it impossible to provide sustainable care.
Read the KOIN News Report →Duke Health Could Drop UnitedHealthcare for 170,000 Patients
Duke Health is in a standoff with UnitedHealthcare that threatens to leave 170,000 North Carolinians without in-network access to their doctors — highlighting that even top-tier academic medical centers are being squeezed by insurer tactics.
Read the News & Observer Report →M Health Fairview: 125,000 Patients at Risk
M Health Fairview warns that UnitedHealthcare's practices could block 125,000 patients from care — following a trend in UnitedHealth's own home state of providers pushing back against the giant.
Read the Star Tribune Report →Corewell Health vs. UnitedHealthcare: Michigan's Battle
Corewell Health, a massive provider in Michigan, is locked in a dispute with UnitedHealthcare. The friction points are consistent with national trends: insurers paying less while demanding more administrative hurdles that delay patient care.
Read the Detroit Free Press Report →USA Health Contract Expires: Patients Left in Limbo
In Alabama, the contract between USA Health and UnitedHealthcare officially expired — immediately thrusting patients into "out-of-network" status, facing astronomical bills or loss of care.
Read the FOX10 News Report →TriHealth Dispute: Cincinnati Patients at Risk
TriHealth in Cincinnati warns that thousands could lose coverage. The pattern is undeniable — regional health systems across the entire country are simultaneously reaching a breaking point with UnitedHealthcare's business practices.
Read the WCPO Report →LCMC Health: 30,000 New Orleans-Area Patients at Risk
LCMC Health and UnitedHealthcare entered a contract dispute threatening to remove 8 major New Orleans-area hospitals from UHC networks — impacting patients across employer-sponsored and ACA exchange plans.
- 30,000 patients affected. Hospitals include East Jefferson General, Touro Infirmary, University Medical Center, and West Jefferson Medical Center.
- LCMC claims UnitedHealthcare wants to pay well below inflation and far below competitor rates, despite LCMC being the "lowest cost provider across the region."
The "Downcoding" Epidemic: Aetna & Cigna
It isn't just UnitedHealthcare. A new explainer details how Aetna and Cigna are implementing aggressive "downcoding" policies — automatically lowering the severity level of emergency room visits to pay less, regardless of what the doctor actually treated. This is algorithmic wage theft against hospitals.
Read the Modern Healthcare Explainer →UnitedHealth's Optum Unit CFO Steps Down
Roger Connor stepped down as CFO of UnitedHealth's Optum unit after less than six months — the latest in a significant period of management reshuffling at UnitedHealth after the company missed earnings targets for the first time in over a decade.
- In the past year, the company has appointed a new group CFO, a new CEO of Optum, and new heads of Optum Rx (pharmacy) and Optum Health (clinics and home-care).
Drug Pricing & PBM Issues
UnitedHealth Marked Up Lifesaving Drugs as Much as 1,000%: FTC
A class-action lawsuit filed in Minnesota accuses UnitedHealthcare, through subsidiaries Optum Rx and Accredo, of significantly marking up specialty drugs — sometimes by thousands of dollars per prescription compared to what the pharmacy actually paid — in violation of ERISA fiduciary duties.
- Alleged markup: dimethyl fumarate (MS drug) — from ~$200 Accredo paid to over $4,000 charged to the patient's plan.
- Alleged markup: lenalidomide (cancer drug) — from ~$300 to over $6,000.
- The lawsuit alleges UHC's PBM (Optum Rx) directs patients to its own affiliated specialty pharmacy (Accredo), creating a closed system for inflated pricing, while hiding the markups through complex contracts and lack of transparency.
UnitedHealth Accused of Overcharging for Drugs in Class Action
A federal class-action filed in Minnesota accuses UnitedHealth Group and Optum Rx of breaching ERISA fiduciary duties by orchestrating a scheme to massively overcharge employer health plans for specialty medications dispensed through affiliated pharmacy Accredo.
- Dimethyl fumarate (MS drug): allegedly acquired for ~$200, billed to the plan at over $4,000.
- Lenalidomide (cancer drug): allegedly acquired for ~$300, billed to the plan at over $6,000.
- Note: Accredo Specialty Pharmacy is owned by Cigna; the lawsuit alleges it collaborates with UHG's Optum Rx in this pricing scheme.
Knowing When and How to Fight Back: Protecting Independent Community Pharmacies from Overbearing PBMs
The top 3 PBMs — CVS Caremark, Express Scripts/Cigna, and Optum Rx/UnitedHealth — control approximately 80% of the prescription drug market and hold immense power over independent community pharmacies through network participation, reimbursement rates, drug formularies, and audit processes.
- PBM tactics include: Spread Pricing (charging health plans more than they pay pharmacies), reimbursements below drug acquisition cost, retroactive Direct and Indirect Remuneration (DIR) fees, patient steering, restrictive network contracts, and burdensome audits.
- Independent pharmacies often face a "take it or leave it" scenario with PBM contracts due to market dominance.
- Legal avenues include state PBM laws, state insurance departments, attorneys general, the ongoing FTC investigation, and arbitration or litigation for contract breaches.
Whistleblower Accounts & Patient Stories
🔍 Investigation Cluster: Nursing Home Kickback Allegations
Revealed: UnitedHealth Secretly Paid Nursing Homes to Reduce Hospital Transfers
A Guardian investigation based on thousands of confidential records and over 20 whistleblower interviews found that UnitedHealth Group secretly paid bonuses to nursing homes for reducing hospital transfers — embedding its own medical teams in approximately 2,000 facilities to push cost-cutting tactics for Medicare Advantage patients.
- The program allegedly directly harmed residents — in several cases, residents showing clear stroke symptoms were not transferred to a hospital after UnitedHealth staff intervened, leading to permanent brain damage and paralysis.
- Whistleblowers alleged staff were pressured to meet financial targets such as a low "admissions per thousand" (APK) rate, which took priority over patient outcomes.
- Following publication, UnitedHealth's shares dropped more than 6%. UnitedHealth filed a defamation lawsuit against The Guardian.
UnitedHealth Shares Fall Again Following Reports on Kickbacks to Nursing Homes
UnitedHealth Group's shares tumbled a second time after follow-up reporting on the alleged nursing home bonus program. Whistleblowers allege the program led to delayed or denied medically necessary hospital care for vulnerable seniors — including at least one resident who suffered brain damage after a delayed stroke transfer.
- Shares fell by as much as 8%, closing down 5.78% at $302.98.
- HSBC analysts downgraded UHG's stock from "Hold" to "Reduce," cutting the price target to a "street-low" of $270.
UnitedHealth Faces Federal Scrutiny Over Whistleblower Claims
U.S. lawmakers from both parties are now "raising concerns and seeking investigations" into UnitedHealth's nursing home programs. Senator Ron Wyden launched a "full investigation," and Representatives Alexandria Ocasio-Cortez and Lloyd Doggett urged the DOJ to "thoroughly review new revelations" of "potential waste, fraud, and abuse at UnitedHealth."
- Sworn declarations allege UnitedHealth "actively avoided medically necessary hospitalizations... in serious life-threatening situations" and drove patients toward signing Do Not Resuscitate (DNR) and Do Not Hospitalize orders to avoid hospital costs.
- A third pending lawsuit alleges UHC "paid kickbacks to nursing homes" for illegal referrals and used "improper marketing tactics" to enroll vulnerable residents, sometimes violating HIPAA.
UnitedHealth Group Resists Shareholder Proposal on Delayed and Denied Care
UnitedHealth Group asked the SEC to block a non-binding shareholder proposal that would require the company to report on the broader economic and public health costs of its practices that delay or deny patient care. The proposal was filed by the Interfaith Center on Corporate Responsibility (ICCR), representing institutional investors.
- Shareholders argued UHG — the 19th-largest company in the world — has such market power that its denial practices could harm the overall US economy by keeping workers sick, indebted, and less productive. More than 5% of US GDP flows through UHG each day.
- UHG argued terms like "public health-related costs" were too vague. Shareholders later withdrew the proposal after UHG challenged it twice, but stated they will continue dialogue with the company.
UnitedHealth Under Scrutiny for Nursing Home Practices — And a Family's Story
UnitedHealth Group faces scrutiny over accusations that it provided financial bonuses to nursing homes to incentivize fewer hospital transfers — with families and whistleblowers alleging residents' medical issues were concealed, delayed, or denied to protect profit margins.
- Nurse practitioner whistleblowers allege the bonus system led to "delays and denials of medically necessary care." Senators Ron Wyden and Elizabeth Warren have launched investigations.
- Vincent Cinque, whose mother and grandmother are both in nursing homes, says their treatment has been "halted for some time" and their experiences align directly with the alleged practices. "It feels like the system is designed to break us, to crack us, and to make us give up. But I don't want to give up on my Mom."
Read the NewsNationNow Article → Watch the NewsNationNow YouTube Coverage →
🤖 AI as Weapon vs. Tool — Same Technology, Provably Different Intent
What they meant for evil can be a force for good. The difference is not the technology — it's the intention. And the intention is provable in the programming.
AI Used By Insurance to Deny
90%
Error Rate
UnitedHealth's nH Predict algorithm — 9 out of 10 denials reversed on appeal. Deployed anyway because only 0.2% of patients fight back.
Estate of Lokken v. UnitedHealth Group → Georgetown Litigation Tracker
AI Used Advocating for Patients
72–96%
Accuracy Range
AI virtual assistant correct answer rate across multiple countries and medical licensing exams — consistently outperforming physician averages of 46–62%. (PMC, 2025)
Read the Peer-Reviewed Study → PMC / NIH
The same underlying technology. Even at its lowest, a 168-point accuracy gap over nH Predict. The only variable is who it was programmed to serve.
AI as a Weapon: UnitedHealth's nH Predict
UnitedHealth Group's nH Predict algorithm — built on 6 million patient records and acquired via the $2.5 billion NaviHealth purchase in 2020 — was deployed across Medicare Advantage plans to automate post-acute care denials. A class action lawsuit (Estate of Lokken v. UnitedHealth Group) alleges the company knowingly used a tool it knew had a 90% error rate, meaning 9 out of 10 denials were reversed on appeal.
- UnitedHealthcare's denial rate for skilled nursing facility admissions rose from 1.4% in 2019 to 12.6% in 2022 — a ninefold increase coinciding directly with nH Predict's deployment. (Senate PSI Report, October 2024)
- The lawsuit alleges UHC "continue[s] to systemically deny claims using their flawed AI model" because only 0.2% of policyholders appeal — meaning the company allegedly calculated that wrongful denial was financially profitable precisely because patients wouldn't fight back.
- Cigna faces parallel allegations over its PxDx system, which a ProPublica investigation found allowed a single medical director to reject 60,000 claims in one month — without reviewing individual patient files.
- On February 13, 2025, a federal judge allowed breach of contract claims to proceed — one of the first times a court has permitted a class action challenging AI-driven health insurance denials to advance toward trial.
The Core Allegation
"Defendants illegally deploy[ed] artificial intelligence in place of real medical professionals to wrongfully deny elderly patients care owed to them under Medicare Advantage Plans by overriding their treating physicians' determinations as to medically necessary care based on an AI model that Defendants know has a 90% error rate."
— Estate of Lokken v. UnitedHealth Group, Class Action Complaint
AI as a Tool: What It Actually Does When Used Correctly
The same underlying AI technology, when directed toward patient benefit rather than denial optimization, demonstrates measurably superior medical knowledge and significantly improves physician accuracy. The technology is not the problem. The intent is.
- A peer-reviewed cross-sectional study published in Bioengineering (PMC, 2025) found that AI outperforms physicians in general medical knowledge across most domains — demonstrating that AI applied to diagnosis and clinical support improves patient outcomes rather than obstructing them.
- An AMA survey found that more than 80% of physicians now use AI professionally — with adoption concentrated in administrative tasks, documentation, and clinical decision support. Physicians report improved efficiency and reduced documentation burden.
- Physicians using AI scribes — documented at institutions including Johns Hopkins and Oak Street Health — show measurably greater engagement with patient complexity, spending more time on diagnosis and less time on paperwork. Patients with complex, multi-system conditions report feeling genuinely seen for the first time.
- The critical distinction: AI in clinical support is calibrated toward diagnostic accuracy. AI in denial systems like nH Predict was calibrated toward cost reduction. The programming intention is the difference — and it is auditable.
The Argument: Intent Is Provable in the Programming
The nH Predict case is not a story about AI being dangerous. It is a story about a corporation deliberately configuring AI to exploit the gap between its error rate and its appeal rate — knowing that patients who were wrongfully denied care would not fight back in sufficient numbers to affect profitability.
| Factor | AI as Weapon (nH Predict) | AI as Tool (Clinical Support) |
|---|---|---|
| Optimization Target | Cost reduction / denial volume | Diagnostic accuracy / patient outcomes |
| Known Error Rate | ~90% (deployed anyway) | Outperforms physicians in most domains |
| Physician Role | Overridden by algorithm | Augmented and supported |
| Patient Impact | Denied care, worsening outcomes, death | Earlier diagnosis, reduced administrative burden |
| Appeal/Review Rate | Exploited: only 0.2% of patients appeal | Designed to be reviewed and improved |
| Regulatory Status | Active litigation; Senate investigated | AMA-endorsed with appropriate guardrails |
Legislative Implication
The Clinical Integrity & Patient Safety Amendment and S.3829 do not oppose AI in healthcare — they demand that AI used in coverage determinations be held to the same standard as clinical AI: accuracy-optimized, physician-reviewed, and auditable. If a denial algorithm's error rate exceeds its appeal rate by design, that is not a technology failure. That is fraud by algorithm. The programming intention is the evidence.
External Health Insurance Watchlists & Resources
UnitedHealth Group Abuse Tracker →
Maintained by: American Economic Liberties Project (AELP)
Compiles news reports, legal filings, and analyses concerning alleged anticompetitive practices, patient care issues, and market power abuses involving UnitedHealth Group and its various subsidiaries across the healthcare industry.
HEALTHCARE — People Over Profit
The POPNYC healthcare page documents multiple "Deaths by Denial," providing specific examples of patients — including Little John Cupp, Nataline Sarkisyan, and Tracy Pike — who died after insurers like UnitedHealthcare, CIGNA, and Blue Cross Blue Shield repeatedly denied their doctors' requests for life-saving or necessary treatments, often deemed "not medically necessary."
- A 2023 class-action lawsuit alleges UHC's "nH Predict" AI algorithm has a 90% error rate but is used anyway — the company allegedly knows only a small percentage of patients will appeal.
- One "medical benefits management company" (EviCore) that insurers hire to deny claims advertises a 3-to-1 return on investment for those insurers.
- A 2022 survey of oncologists found 42% of prior authorizations were delayed, with doctors attributing "loss of life" to these delays 36% of the time.